The government reshuffle and what it could mean for community pharmacy

Written by Molly Benson, Senior Content Producer, 18th May  

Politics and pharmacy have always been linked but rarely has that relationship felt as immediate as it does now. Following the recent resignation of Wes Streeting as Health Secretary and the appointment of James Murray to lead the Department of Health and Social Care (DHSC) in his place, community pharmacy finds itself once again watching Westminster closely, trying to understand what these changes could mean for a sector already navigating significant transformation.  

At first glance, a ministerial reshuffle might feel distant from day-to-day pharmacy practice within the community. Pharmacies still open their doors each morning, prescriptions still need dispensing, and consultations continue regardless of who occupies which role. Yet in practice, these political changes matter. They shape the direction of NHS reform, influence funding negotiations, and determine how strongly community pharmacy is prioritised within the wider healthcare strategy. 

In an interview with Independent Community Pharmacist, Numark chairman Harry McQuillan stated “Any major reshuffle within the Department of Health, especially any change to Stephen Kinnock’s current role as pharmacy minister, risks delaying progress on the issues that matter most to community pharmacy, including sustainable funding, workforce pressures and the expansion of clinical services”. 

The timing of this shift is particularly significant. Community pharmacy is already operating during a period of major transition, balancing increasing clinical responsibility with ongoing financial pressure. The rollout of Pharmacy First, the continued expansion of independent prescribing, and the wider move towards neighbourhood health models have all placed pharmacy much more visibly within frontline care. At the same time however, concerns around workforce, capacity, and sustainability remain unresolved. 

Wes Streeting’s time as Health Secretary has seen NHS reform continue to be centred around shifting care closer to communities. Much of the language surrounding neighbourhood health, preventative care, and reducing pressure on hospitals aligned naturally with the direction community pharmacy has been moving towards over recent years. While pharmacies were not always explicitly placed at the centre of those conversations, there was a collective awareness that the sector had an opportunity to become more integrated into local healthcare delivery. 

That broader shift towards community-based care has already started to influence pharmacy services. Pharmacy First, blood pressure services, contraception provision, and expanded vaccination pathways all reflect a wider NHS ambition to make pharmacies more clinically active and more accessible points of care. Across the sector, community pharmacy professionals are increasingly expected to work not only as dispensers of medicines, but as clinicians embedded within primary care systems. 

The appointment of James Murray therefore raises an immediate question: will this direction continue, accelerate, or begin to change? At this stage, there are still relatively few concrete answers. Early reporting suggests that Murray is expected to continue much of Labour’s existing NHS reform agenda, although the detail of how community pharmacy specifically fits within that remains unclear.  

What is already evident however is the concern emerging across the sector about disruption to ongoing contractual negotiations, with one of the biggest anxieties centring around the Community Pharmacy Contractual Framework (CPCF). Negotiations around community pharmacy funding and future service development were already progressing slowly before the reshuffle, with many in the sector frustrated by continued delays and uncertainty. Several pharmacy leaders have warned that political instability could now risk slowing progress even further at a time when pharmacies are already under significant financial strain.  

Those concerns are not without context. Community Pharmacy England has repeatedly highlighted the gap between increasing workload and available funding, despite the expansion of clinical services and the growing expectation that pharmacies will absorb more demand from elsewhere in the NHS.  

At the same time, the sector is preparing for one of its most significant professional changes in decades. From 2026 onwards, all newly qualified pharmacists will graduate as independent prescribers. Rather than operating primarily through patient group directions or referral pathways, pharmacies may increasingly deliver more direct prescribing and clinical management within local communities. 

Yet, much like wider NHS reform, the detail of what this will look like in practice is still emerging. Questions remain around supervision, workforce readiness, commissioning models, and how prescribing responsibilities will actually function in busy community pharmacy settings.  

As Henry Gregg stated in the National Pharmacy Association’s (NPA) weekly round-up, “With a new Secretary of State in James Murray – and whatever happens to the rest of Government – we need the politicians to see pharmacy differently and to implement change.” 

Whilst the change in Health Secretary may influence the pace or direction of some of these developments, it is unlikely to remove the wider expectation that pharmacy will play a growing role within frontline community care. 

What remains less certain is how quickly the operational detail will follow. For community pharmacy, the coming months may be less about dramatic policy announcements, and more about whether the systems, funding, and support structures begin to catch up with the ambition that has already been set.